Altos Labs
Altos Labs is a biotechnology company focused on restoring cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that occur throughout life. Learn more about Altos.
- Est. revenue
- $20M–$50M
- Total raised
- $3B
- Latest round
- Series A
- Employees
- 549
Funding & revenue at Altos Labs
How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.
Estimated annual revenue
$20M–$50M
Modeled range, not company-reported
Total capital raised
$3B
5 known investors
Latest round
Series A · $3B
Sep 2021
Investors
Growth signals
How fast Altos Labs is adding people, roles, and audience.
Employees
549
Reported band 201-500
Open roles
1
-0.9% year over year
LinkedIn followers
68.7K
+19.5% year over year
Headcount change
- MoM
- -0.9%
- -5 people
- QoQ
- -0.4%
- -2 people
- 6mo
- -3%
- -17 people
- YoY
- -5.5%
- -32 people
- 2yr
- -3.5%
- -20 people
Team composition
Where Altos Labs concentrates its people — a read on which function a fractional leader would plug into.
By function
- Research30556%
- Engineering468%
- Operations438%
- Information Technology173%
- Administrative163%
- Human Resources153%
- Military And Protective Services143%
- Program And Project Management112%
By region
- United States401
- California, United States378
- San Francisco Bay Area237
- San Diego Metropolitan Area133
- San Diego, CA128
- United Kingdom115
Inside Altos Labs
What the business focuses on, where it operates, and how employees rate it.
Specialties
Categories
Markets
Competitors
Companies in the same market as Altos Labs.
Altos Labs in the news
Recent coverage picked up alongside the firmographic refresh.
- Silicon Valley Billionaires Want to Reverse Aging: First Human Trial Offers Encouraging Signs
Oct 2026
- The US loves longevity. Can Europe turn it into venture category
Sep 2026
- Sam Altman's longevity company is testing an extra-strength Alzheimer's drug after disappointing trial results
Aug 2026
- Akram Baharlouei: Flow Matching Beats Transformers in Single-Cell Biology, as Altos Labs Readies First Reprogramming Medicine
Jul 2026
- AI in Biology: From Tokens to Cells at Altos Labs
Jul 2026
- Squid Raises $6M in Funding
May 2026
Jobs
1Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed October 23, 2026.
About this page
This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Altos Labs, you can claim this page to manage and enhance it.